Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| International Classification of Diseases | 2 | 2018 | 71 | 1.150 |
Why?
|
| Myocytes, Cardiac | 5 | 2014 | 316 | 0.790 |
Why?
|
| Poverty Areas | 1 | 2020 | 37 | 0.680 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 149 | 0.620 |
Why?
|
| Clinical Coding | 1 | 2018 | 24 | 0.590 |
Why?
|
| Hospitals | 1 | 2020 | 308 | 0.570 |
Why?
|
| Sulfonylurea Receptors | 2 | 2014 | 50 | 0.480 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 244 | 0.420 |
Why?
|
| Embryonic Stem Cells | 3 | 2008 | 82 | 0.390 |
Why?
|
| Heart | 2 | 2014 | 580 | 0.370 |
Why?
|
| Biological Clocks | 2 | 2008 | 74 | 0.360 |
Why?
|
| Algorithms | 4 | 2022 | 1915 | 0.340 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1459 | 0.300 |
Why?
|
| Sinoatrial Node | 1 | 2007 | 12 | 0.290 |
Why?
|
| Gap Junctions | 1 | 2008 | 144 | 0.290 |
Why?
|
| Pacemaker, Artificial | 1 | 2008 | 96 | 0.290 |
Why?
|
| Cardiomyopathies | 4 | 2014 | 269 | 0.290 |
Why?
|
| Machine Learning | 2 | 2022 | 271 | 0.290 |
Why?
|
| Tissue Engineering | 1 | 2008 | 196 | 0.270 |
Why?
|
| Fibroblasts | 2 | 2010 | 762 | 0.250 |
Why?
|
| KATP Channels | 2 | 2014 | 19 | 0.200 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 1987 | 0.180 |
Why?
|
| Hospital Mortality | 2 | 2021 | 416 | 0.170 |
Why?
|
| Sodium Channels | 2 | 2012 | 130 | 0.160 |
Why?
|
| Nursing Stations | 1 | 2018 | 1 | 0.160 |
Why?
|
| Environment Design | 1 | 2018 | 9 | 0.160 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 336 | 0.160 |
Why?
|
| Critical Illness | 1 | 2021 | 315 | 0.160 |
Why?
|
| Databases, Genetic | 3 | 2014 | 270 | 0.150 |
Why?
|
| Intensive Care Units | 1 | 2021 | 399 | 0.150 |
Why?
|
| Connexin 43 | 2 | 2008 | 94 | 0.140 |
Why?
|
| Mice | 8 | 2014 | 11898 | 0.140 |
Why?
|
| Urinary Catheterization | 1 | 2017 | 36 | 0.140 |
Why?
|
| Telemetry | 1 | 2017 | 36 | 0.140 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 53 | 0.140 |
Why?
|
| Medicare | 1 | 2020 | 428 | 0.130 |
Why?
|
| Penicillins | 1 | 2016 | 20 | 0.130 |
Why?
|
| Drug Hypersensitivity | 1 | 2016 | 37 | 0.130 |
Why?
|
| Hospitalization | 2 | 2022 | 898 | 0.130 |
Why?
|
| Inpatients | 1 | 2018 | 313 | 0.120 |
Why?
|
| Risk Factors | 3 | 2021 | 5576 | 0.120 |
Why?
|
| Length of Stay | 1 | 2018 | 755 | 0.120 |
Why?
|
| Animals, Newborn | 2 | 2014 | 525 | 0.120 |
Why?
|
| Sarcolemma | 1 | 2014 | 31 | 0.120 |
Why?
|
| Genes, p16 | 1 | 2014 | 8 | 0.120 |
Why?
|
| Annexin A6 | 1 | 2014 | 10 | 0.110 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2014 | 21 | 0.110 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 29 | 0.110 |
Why?
|
| MyoD Protein | 1 | 2014 | 16 | 0.110 |
Why?
|
| Vimentin | 1 | 2014 | 46 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2014 | 30 | 0.110 |
Why?
|
| Humans | 15 | 2022 | 90422 | 0.110 |
Why?
|
| Cell Membrane | 2 | 2014 | 679 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2014 | 134 | 0.110 |
Why?
|
| Animals | 9 | 2014 | 27606 | 0.100 |
Why?
|
| Genome, Human | 2 | 2014 | 792 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2012 | 112 | 0.100 |
Why?
|
| Wound Healing | 1 | 2014 | 365 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 693 | 0.100 |
Why?
|
| Electrocardiography | 2 | 2012 | 498 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 1581 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 309 | 0.090 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 126 | 0.090 |
Why?
|
| Genetic Variation | 3 | 2014 | 1381 | 0.090 |
Why?
|
| Alternative Splicing | 2 | 2014 | 214 | 0.090 |
Why?
|
| Lamin Type A | 1 | 2010 | 26 | 0.090 |
Why?
|
| Muscular Dystrophies | 1 | 2010 | 55 | 0.090 |
Why?
|
| United States | 2 | 2021 | 7135 | 0.090 |
Why?
|
| Myocardial Contraction | 2 | 2012 | 252 | 0.090 |
Why?
|
| Receptors, Drug | 1 | 2010 | 54 | 0.090 |
Why?
|
| Mitochondria | 1 | 2014 | 557 | 0.090 |
Why?
|
| Male | 6 | 2021 | 42882 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 115 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 3261 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2010 | 143 | 0.080 |
Why?
|
| Software | 1 | 2014 | 669 | 0.080 |
Why?
|
| Heart Ventricles | 3 | 2014 | 791 | 0.080 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2010 | 122 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2012 | 201 | 0.080 |
Why?
|
| Biomedical Engineering | 1 | 2008 | 20 | 0.080 |
Why?
|
| Transcriptome | 1 | 2014 | 667 | 0.080 |
Why?
|
| Female | 5 | 2021 | 46802 | 0.080 |
Why?
|
| Aged | 3 | 2021 | 19371 | 0.080 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 3 | 2014 | 32 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2008 | 403 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 1240 | 0.070 |
Why?
|
| Chromosome Mapping | 1 | 2010 | 1074 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 473 | 0.070 |
Why?
|
| Chlorofluorocarbons, Methane | 1 | 2006 | 1 | 0.070 |
Why?
|
| Cell Communication | 1 | 2007 | 201 | 0.070 |
Why?
|
| Epinephrine | 1 | 2006 | 89 | 0.070 |
Why?
|
| Kinetics | 1 | 2008 | 1541 | 0.060 |
Why?
|
| Rats | 2 | 2007 | 4057 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2010 | 1229 | 0.060 |
Why?
|
| Intestinal Diseases | 1 | 1984 | 79 | 0.050 |
Why?
|
| Myosin Heavy Chains | 2 | 2014 | 92 | 0.050 |
Why?
|
| Intracellular Space | 2 | 2014 | 38 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1544 | 0.050 |
Why?
|
| Intestine, Small | 1 | 1984 | 299 | 0.050 |
Why?
|
| Survival Rate | 2 | 2021 | 1899 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2593 | 0.050 |
Why?
|
| Protein Transport | 2 | 2014 | 424 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2021 | 9307 | 0.040 |
Why?
|
| Mutation | 1 | 2010 | 4170 | 0.040 |
Why?
|
| Neoplasms | 1 | 2014 | 3020 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 26295 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 955 | 0.040 |
Why?
|
| Heart Failure | 1 | 2007 | 1269 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 431 | 0.040 |
Why?
|
| Cost Control | 1 | 2017 | 45 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 1741 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 1593 | 0.030 |
Why?
|
| Adult | 4 | 2018 | 26916 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 169 | 0.030 |
Why?
|
| Child | 2 | 2018 | 7211 | 0.030 |
Why?
|
| LIM Domain Proteins | 1 | 2014 | 25 | 0.030 |
Why?
|
| Genes, Modifier | 1 | 2014 | 5 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1216 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 19 | 0.030 |
Why?
|
| Membranes | 1 | 2014 | 37 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3689 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2014 | 36 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3805 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 372 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 200 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 459 | 0.030 |
Why?
|
| Connectin | 1 | 2012 | 5 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2012 | 19 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 314 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2012 | 51 | 0.030 |
Why?
|
| Pedigree | 1 | 2014 | 969 | 0.030 |
Why?
|
| Sarcomeres | 1 | 2012 | 27 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 82 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2012 | 121 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2012 | 132 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2019 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 2893 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2012 | 212 | 0.020 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 5 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 870 | 0.020 |
Why?
|
| Dysferlin | 1 | 2010 | 14 | 0.020 |
Why?
|
| Myoblasts | 1 | 2010 | 32 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2010 | 117 | 0.020 |
Why?
|
| Connexins | 1 | 2012 | 202 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2012 | 281 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 491 | 0.020 |
Why?
|
| Coronary Vasospasm | 1 | 2010 | 8 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 294 | 0.020 |
Why?
|
| Lysosomes | 1 | 2010 | 113 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2012 | 284 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 354 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 615 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1122 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 722 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 277 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 441 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2012 | 408 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 680 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2010 | 603 | 0.020 |
Why?
|
| Myocardium | 1 | 2010 | 573 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 385 | 0.020 |
Why?
|
| Bromochlorofluorocarbons | 1 | 2006 | 1 | 0.020 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2006 | 2 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2006 | 144 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2421 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 997 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 307 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 909 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2891 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 2022 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2401 | 0.010 |
Why?
|
| Action Potentials | 1 | 2006 | 602 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 6409 | 0.010 |
Why?
|
| Radiography | 1 | 1984 | 809 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 9336 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 2029 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1984 | 471 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 3416 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1984 | 4345 | 0.010 |
Why?
|